Hepatic hemangioma MRI

Hepatic hemangioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hepatic Hemangioma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hepatic hemangioma MRI On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hepatic hemangioma MRI All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hepatic hemangioma MRI
CDC on Hepatic hemangioma MRI
Hepatic hemangioma MRI in the news
Blogs on Hepatic hemangioma MRI
Directions to Hospitals Treating Hepatic hemangioma
Risk calculators and risk factors for Hepatic hemangioma MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]

Overview

On MRI, hepatic hemangioma is characterized by hypointensity on T1-weighted imaging and hyperintense on T2-weighted imaging.

MRI

On MRI, hepatic hemangioma is characterized by:

• T1: Hypointense relative to liver parenchyma
• T2: Hyperintense relative to liver parenchyma
• Portal venous enhancement: Peripheral nodular enhancement
• Delayed enhancement: Lesion fills in the contrast

Gallery

Shown below is MRI image of a patient with hepatic hemangioma.

• 
  _{MRI reveals a lobullated T2 hyperintense lesion in the right lobe segments VI and VII.}